Bone Biologics short interest last week

 Bone Biologics Co. (NASDAQ:BBLG) was the recipient of a large growth in short interest in July. As of July 15th, there was short interest totalling 5,300 shares, a growth of 562.5% from the June 30th total of 800 shares. Based on an average trading volume of 835,900 shares, the short-interest ratio is presently 0.0 days. Currently, 1.0% of the shares of the stock are short sold.

https://www.defenseworld.net/2024/07/26/short-interest-in-bone-biologics-co-nasdaqbblg-grows-by-562-5.html